202 related articles for article (PubMed ID: 31592410)
1. Therapeutic Targeting of
Fang E; Wang X; Yang F; Hu A; Wang J; Li D; Song H; Hong M; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
Adv Sci (Weinh); 2019 Oct; 6(19):1900581. PubMed ID: 31592410
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
[TBL] [Abstract][Full Text] [Related]
3. HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression.
Song H; Li D; Wang X; Fang E; Yang F; Hu A; Wang J; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
J Hematol Oncol; 2020 Mar; 13(1):24. PubMed ID: 32216806
[TBL] [Abstract][Full Text] [Related]
4. Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF.
Zhao X; Li D; Huang D; Song H; Mei H; Fang E; Wang X; Yang F; Zheng L; Huang K; Tong Q
Mol Ther; 2018 Mar; 26(3):755-773. PubMed ID: 29398485
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Li H; Yang F; Hu A; Wang X; Fang E; Chen Y; Li D; Song H; Wang J; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
EMBO Mol Med; 2019 Dec; 11(12):e10835. PubMed ID: 31709724
[TBL] [Abstract][Full Text] [Related]
6. HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation.
Song H; Wang J; Wang X; Yuan B; Li D; Hu A; Guo Y; Cai S; Jin S; Zhou Y; Li Q; Chen G; Gao H; Zheng L; Tong Q
Oncogene; 2022 Apr; 41(17):2505-2519. PubMed ID: 35318442
[TBL] [Abstract][Full Text] [Related]
7. Myeloid Zinc Finger 1 (MZF1) Maintains the Mesenchymal Phenotype by Down-regulating IGF1R/p38 MAPK/ERα Signaling Pathway in High-level MZF1-expressing TNBC cells.
Yue CH; Liu JY; Chi CS; Hu CW; Tan KT; Huang FM; Pan YR; Lin KI; Lee CJ
Anticancer Res; 2019 Aug; 39(8):4149-4164. PubMed ID: 31366500
[TBL] [Abstract][Full Text] [Related]
8. Nonstructural maintenance of chromatin condensin I complex subunit G promotes the progression of glioblastoma by facilitating Poly (ADP-ribose) polymerase 1-mediated E2F1 transactivation.
Hou J; Huang P; Xu M; Wang H; Shao Y; Weng X; Liu Y; Chang H; Zhang L; Cui H
Neuro Oncol; 2023 Nov; 25(11):2015-2027. PubMed ID: 37422706
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of FUBP3 phase separation by GATA2-AS1 inhibits malate-aspartate shuttle and neuroblastoma progression via modulating SUZ12 activity.
Wang X; Guo Y; Chen G; Fang E; Wang J; Li Q; Li D; Hu A; Bao B; Zhou Y; Gao H; Song J; Du X; Zheng L; Tong Q
Oncogene; 2023 Sep; 42(36):2673-2687. PubMed ID: 37537343
[TBL] [Abstract][Full Text] [Related]
10. miRNA-337-3p inhibits gastric cancer progression through repressing myeloid zinc finger 1-facilitated expression of matrix metalloproteinase 14.
Zheng L; Jiao W; Mei H; Song H; Li D; Xiang X; Chen Y; Yang F; Li H; Huang K; Tong Q
Oncotarget; 2016 Jun; 7(26):40314-40328. PubMed ID: 27259238
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis.
Mu B; Lv C; Liu Q; Yang H
J Biochem; 2021 Sep; 170(1):41-50. PubMed ID: 33788950
[TBL] [Abstract][Full Text] [Related]
12. Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation.
Kumari A; Iwasaki T; Pyndiah S; Cassimere EK; Palani CD; Sakamuro D
Cell Death Differ; 2015 Feb; 22(2):311-22. PubMed ID: 25257171
[TBL] [Abstract][Full Text] [Related]
13. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.
Jia P; Wei E; Liu H; Wu T; Wang H
IUBMB Life; 2020 Dec; 72(12):2627-2636. PubMed ID: 33031637
[TBL] [Abstract][Full Text] [Related]
14. Long Noncoding RNA NHEG1 Drives β-Catenin Transactivation and Neuroblastoma Progression through Interacting with DDX5.
Zhao X; Li D; Yang F; Lian H; Wang J; Wang X; Fang E; Song H; Hu A; Guo Y; Liu Y; Li H; Chen Y; Huang K; Zheng L; Tong Q
Mol Ther; 2020 Mar; 28(3):946-962. PubMed ID: 31982037
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.
Zhang HY; Xing MQ; Guo J; Zhao JC; Chen X; Jiang Z; Zhang H; Dong Q
Cancer Cell Int; 2019; 19():313. PubMed ID: 31787850
[TBL] [Abstract][Full Text] [Related]
16. LncRNA-SLC16A1-AS1 induces metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1.
Logotheti S; Marquardt S; Gupta SK; Richter C; Edelhäuser BAH; Engelmann D; Brenmoehl J; Söhnchen C; Murr N; Alpers M; Singh KP; Wolkenhauer O; Heckl D; Spitschak A; Pützer BM
Theranostics; 2020; 10(21):9620-9643. PubMed ID: 32863950
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the DNA-binding properties of the myeloid zinc finger protein MZF1: two independent DNA-binding domains recognize two DNA consensus sequences with a common G-rich core.
Morris JF; Hromas R; Rauscher FJ
Mol Cell Biol; 1994 Mar; 14(3):1786-95. PubMed ID: 8114711
[TBL] [Abstract][Full Text] [Related]
18. PHF20 collaborates with PARP1 to promote stemness and aggressiveness of neuroblastoma cells through activation of SOX2 and OCT4.
Long W; Zhao W; Ning B; Huang J; Chu J; Li L; Ma Q; Xing C; Wang HY; Liu Q; Wang RF
J Mol Cell Biol; 2018 Apr; 10(2):147-160. PubMed ID: 29452418
[TBL] [Abstract][Full Text] [Related]
19. Association of PARP1 polymorphisms with response to chemotherapy in patients with high-risk neuroblastoma.
Avitabile M; Lasorsa VA; Cantalupo S; Cardinale A; Cimmino F; Montella A; Capasso D; Haupt R; Amoroso L; Garaventa A; Quattrone A; Corrias MV; Iolascon A; Capasso M
J Cell Mol Med; 2020 Apr; 24(7):4072-4081. PubMed ID: 32103589
[TBL] [Abstract][Full Text] [Related]
20. c-Myc-activated USP2-AS1 suppresses senescence and promotes tumor progression via stabilization of E2F1 mRNA.
Li B; Zhang G; Wang Z; Yang Y; Wang C; Fang D; Liu K; Wang F; Mei Y
Cell Death Dis; 2021 Oct; 12(11):1006. PubMed ID: 34707111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
